Androgens stimulate the development and growth of the male external genitalia. Because hypospadias is the most common congenital defect of the male urethra and because in most cases the cause of this malformation is unknown, we examined the hypothesis that the etiology of the severe forms of this disorder, which is frequently associated with other genital anomalies, might be explained by receptor abnormalities. Intracellular and nuclear binding of androgens were determined in cultured genital skin fibroblasts from 10 males who underwent circumcision for phimosis (controls A), 2 patients with 5a-reductase deficiency (controls B), and 11 patients with severe forms of hypospadias of unknown etiology.
Introduction
The conversion ofthe indifferent urogenital tract into the male phenotype is mediated by testicular hormones, principally androgens, secreted by the fetal testis during a critical period of embryogenesis. In accordance with this concept, several syndromes of hereditary male pseudohermaphroditism result either from deficient testicular testosterone secretion or from resistance oftarget organs to the action ofandrogen. For example, the autosomal recessive disorder pseudovaginal perineoscrotal hypospadias (5a-reductase deficiency) results from a defective 5a-reduction of testosterone to dihydrotestosterone (1, 2) . Other disorders such as testicular feminization or the Reifenstein syndrome, which are inherited in an X-linked fashion, result from abnormalities of the high-affinity intracellular androgen receptor protein (1) (2) (3) . These disorders are, however, rare; for example, testicular feminization, the most common of these disorders, occurs at an incidence of -1 in 20,000 to 1 in 60,000 male births.
In contrast to these rare but well-characterized forms of male pseudohermaphroditism, the etiology in many instances of incomplete virilization, particularity hypospadias, the most common congenital defect in males with an estimated incidence of 0.1-0.8% (4) (5) (6) , is less well understood. We have therefore examined the hypothesis that the etiology of severe forms of hypospadias, which are frequently associated with other anomalies of the external genitalia, might be explained by receptor abnormalities. Intracellular and nuclear binding were assessed in cultured genital fibroblasts in normal males (controls A), two patients with 5a-reductase deficiency (controls B), and patients with severe forms of hypospadias of unknown etiology.
Methods
Materials. Silica gel TLC sheets with plastic back (Polygram Sil G-Hy) were from Macherey and Nagel, Duren, FRG. [1,2,4,5,6,7- Source of tissue. The fibroblast strains used in this study were derived from explants of genital skin (scrotum or foreskin) from 10 normal males, 2 patients with Sa-reductase deficiency and 11 patients with severe forms of hypospadias (Tables I and II) . The tissue was obtained either at surgery for circumcision or repair of developmental defects of the urogenital tract. Biopsies of minors were performed with the consent from the parents. The biopsies were obtained from various university and city hospitals. Immediately after biopsy, the tissue was brought into a cryotube (1.8 ml volume) containing MEM fortified with 20% FCS and mailed to our laboratory. Detailed clinical information on each patient (karyotype, history, drug intake by the patient's mother during the first trimester of pregnancy, penile size, description of the genitalia, and the results of serum testosterone determination before and after human chorionic gonadotropin stimulation) were provided by the referring physicians and are listed in Table II . A description of one patient with 5a-reductase deficiency (cell strain GS 180) has been published previously (7) .
Cell culture and incubation ofcells with [3H]DHT. The skin fibroblasts were established from the genital biopsies as described (8, 9) and were used between passages 5 and 12. Cells from stock dishes (100 X 20 mm) were dissociated with trypsin-EDTA and seeded on day 0 at a concentration of -200,000 cells in 100 X 20 mm dishes (Falcon Labware, Oxnard, CA). On day 3 the medium was replaced with fresh growth medium (MEM plus 10% FCS). On day 6 the medium was removed, the cells were washed twice with 4 ml of PBS, and 8 ml of MEM without FCS were added to each dish. On day 7 the medium was removed again and the monolayers were incubated in duplicate with varying concentrations of [3H]DHT (0.25-2.0 nM) in MEM with or without a 500-fold excess of nonradioactive DHT for 60 min in a humified incubator at 37°C in the presence of 5% CO2.
Whole cell binding assay. Binding was assessed using (with minor modifications) the methods described by Brown et al. (10, 11) . In brief, after incubation, the medium was removed, and the monolayers were washed three times with 5 ml ice-cold Tris-NaCl buffer (0.9% NaCl, 20 mM Tris-HCl, pH 7.4). All subsequent procedures were conducted at 0-4°C. Cells were harvested in 5 ml Tris-EDTA-glycerol (TEG) buffer (20 mM Tris-HCl, 1.5 mM EDTA, and 10% [vol/vol] glycerol, pH 7.4) by scraping with a rubber policeman. Cell suspensions from each ofthe two dishes containing corresponding steroid concentrations were combined (10 ml), and a 2-ml aliquot of the suspension was used for the whole cell binding assay, whereas in the remainder (8 ml) the nuclear uptake was assessed.
Centrifugation of the cell suspension for 10 min at 800 g yielded a pellet ofwhole cells. After the supernatant was aspirated, the pellet was resuspended in 0.9 ml Tris-EDTA-KCl (TEK) buffer (20 mM TrisHCl, 1.5 mM EDTA, and 0.5 M KCl, pH 7.4) and subjected to sonic disruption using an ultrasonic system (model 1510, Labsonic; Braun Melsungen, FRG) (20,000 Hz, 300 W maximum power). Samples were exposed to two 5-s periods of sonication at 50 W power using a needle probe (4 mm diam). The cell lysates were centrifuged at 1,600 g, and two aliquots of the supernatant (300 ,ul each) were taken for the determination of total or nonspecific binding, and the DNA content was measured in a I00-,gl aliquot by the method described by Collier et al. (12) .
Adsorption of free steroid was performed by adding 600 Al of dextran-coated charcoal suspension (20 mM Tris-HCl, 1.5 mM EDTA, 0.1% gelatine, 0.05% dextrane T 70, and 0.5% activated charcoal) to each tube, which was then stirred several times over a 10-min period. The charcoal was pelleted by centrifugation at 2,500 g for 15 min, and the radioactivity was counted in a liquid scintillation counter (model 300C; Packard Instrument Co., Downers Grove, IL) in a 500-Ml aliquot of the supernatant pipetted into 10 ml Riafluor. Specific receptor bound steroid was calculated as the difference between total and nonspecific binding and corrected for DNA content. The maximum binding capacity (Bmax) and the apparent dissociation constant (Kd) of the androgen receptor were determined from Scatchard plots (13) analyzed by a linear regression program using a calculator (TI 59; Texas Instruments, Inc., Dallas, TX).
Nuclear [3H]DHT binding. An 8-ml aliquot of the cell suspension saved for preparation of purified nuclei from intact fibroblasts was removed and nuclear binding was performed as described by Collier et al. (12) , except that the final purification step by ultracentrifugation was modified to our laboratory conditions. For this purpose the nuclear pellet was suspended in 6 ml Tris-sucrose buffer by vortexing for 1 min. 5.8 ml of this nuclear suspension were then layered over 5.8 ml hypertonic buffer solution, and the mixture was centrifuged at 100,000 g for 75 min at 1°C in an ultracentrifuge (model TGA-50, Kontron Analytical, Everett, MA) using a fixed angle TFT 50.13 rotor. The supernatant was aspirated and the cellulose-acetobutyrate tubes were cut -1.5 cm above the bottom. The nuclear pellet was suspended in GS, genital skin; -, negative; +, mother received gestagen-estrogen injections during second and third month of pregnancy.
1.0 ml TEK buffer followed by one passage through a 25-gauge needle.
An 0.5-ml aliquot was then put into 10 ml Riafluor for determination of radioactivity, and two aliquots of 0.2 ml each were used for DNA Cell strain GS-70 Statistical analysis. Statistical analysis of the data was performed using the t test and the Wilcoxon U test.
Results
Karyotypes were obtained in 9 of the 11 patients and were found to be 46,XY (Table II) . Of the two patients in which this parameter was not assessed, a 26-yr-old man had undergone orchidopexy for cryptorchidism of the right testis and a 10-yrold boy had penile hypospadias. The human chorionic gonadotropin (hCG) stimulation tests were performed in all subjects except a 26-yr-old patient who had basal testosterone serum levels within the normal male range (Table II) .
A normal response of serum testosterone to hCG was found in nine patients, whereas in one boy, serum testosterone after hCG stimulation (0.6 ng/ml) remained below the lowest values measured (0.83 ng/ml) in a control cohort of 30 boys with normal penile development. 5a-reductase activity was within the normal range (> 1 pmol m-g protein-' . h-') in all but one patient with hypospadias of unknown etiology. As expected, 5a-reductase activity was < 1 pmol* mg protein-' * h-' in both 5a-reductase deficiency patients.
The methods that have been used for measurement of androgen binding in intact fibroblasts and isolated nuclei are illustrated diagrammatically in Fig. 1 Figure 1 . Diagram of methods.
to be free of cytoplasmic contamination, as has been demonstrated before (12) .
To determine the reproducibility of our procedures, total cellular and nuclear binding were measured in two cell strains on three occasions. In one experiment in two cell strains similar results were also obtained with a fixed angle rotor and a rotor equipped with a swinging bucket (Table III) .
Representative binding curves from cell strains derived from the genital skin of a boy with normal male genitalia and from two patients with hypospadias of unknown etiology are shown in Fig. 2 A-C. Nuclear binding in these two patients with hypospadias differed from that seen in males with normal genital development; namely, nuclear binding was reduced or absent. High-affinity androgen binding was then assessed in intact fibroblasts and nuclei in a total of 23 cell strains (Tables  I and II 
Discussion
This study has examined androgen binding in cultured human genital skin fibroblasts from males with incomplete virilization of the external genitalia. Among the 11 patients studied, 10 had severe hypospadias, in some instances associated with other genital abnormalities. We selected these patients in an attempt to avoid subtle abnormalities of the external genitalia. Skin fibroblasts were chosen because these cells retain the biochemical properties of genital skin with regard to androgen binding and metabolism. This model also allows investigation under defined chemical conditions and is not affected by a limitation of tissue. Two major findings emerge from our study. First, in a subgroup of patients with hypospadias (6 out of 1 1), androgen uptake in intact genital fibroblasts was below the minimum values determined in control groups. These results are in accordance with several previous studies. Svensson and Snochowsky (15) were the first who reported a lower binding of methyltrienolone to receptor proteins offoreskin homogenates of boys with hypospadias compared with appropriate controls with normal genital development. Later, Keenan et al. (16) reported a lower mean [3H]DHT binding in fibroblasts cultured from foreskin of 28 infants with simple idiopathic hypospadias as compared with a control group. Similar results have also been observed in our laboratory (17, 18) : in a group of 10 patients with idiopathic hypospadias, mean maximum specific binding of methyltrienolone in cultured genital skin fibroblasts was lower than in 8 males with normal penile development.
Second, nuclear binding in cell strains from patients with hypospadias of unknown etiology was in all instances lower than in the control groups. In 6 of 11 patients no nuclear binding was found. From a theoretical standpoint, several possible biochemical mechanisms may be responsible for these Eil et al. (21) , who used crude nuclear preparations, we have applied a more vigorous method to yield nuclei that are essentially free of endoplasmic reticulum (12) .
Several other aspects of this study deserve comment. Most ofthe studies in patients with hypospadias have addressed only narrow etiological parameters. To provide a more comprehensive study, we obtained genetic, clinical, endocrine, and biochemical profiles of the patients. Aside from the described receptor abnormalities, we ascertained in some of the patients the following anomalies. First, the history of one patient revealed that a progestin-estrogen preparation was administered to the mother during the second and third month of gestation, a time that coincides with the critical period ofgenital developDihydrotestosterone Receptors in Severe Hypospadias 667 ment. If Aarskog's hypothesis (22) that maternal ingestion of estrogen-gestagen preparation during the first trimester of pregnancy may cause hypospadias is correct, it is conceivable that this factor, in addition to the defective nuclear androgen uptake observed in this patient, had a negative synergistic effect on penile development; however, up to now, Aarskoog's hypothesis has not been substantiated. Second, in one patient a subnormal testosterone response to hCG stimulation was observed. As it is well documented that any of at least five enzymatic errors that can cause defective androgen synthesis result in incomplete virilization of the male during embryogenesis, it is conceivable that the impaired testosterone secretion observed in this patient has also contributed to their genital malformation. Indeed, Knorr et al. (23) have demonstrated a subnormal testosterone response to hCG stimulation in 36 boys with hypospadias, whereas Walsh et al. (24) were unable to document such a defect in 11 prepuberal boys with hypospadias.
Third, in one patient with defective nuclear androgen uptake deficient activity of the enzyme 5a-reductase was found. In analogy with previous studies by Jukier et al. (25) , it is conceivable that 5a-reductase deficiency in this patient was secondary to the androgen receptor defect determined in his genital fibroblasts.
In conclusion, we have examined clinical, endocrine, and biochemical parameters relevant to the etiology of hypospadias in patients with severe forms of this disorder. The most consistent finding in these studies was defective intracellular and/or nuclear binding in some of the patients. We interpret these data to suggest that defective intracellular and/or nuclear binding in some patients with severe hypospadias might be the cause of the defective genital development.
